116 related articles for article (PubMed ID: 16824752)
1. Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial SAR.
Finke PE; Meurer LC; Levorse DA; Mills SG; Maccoss M; Sadowski S; Cascieri MA; Tsao KL; Chicchi GG; Metzger JM; Macintyre DE
Bioorg Med Chem Lett; 2006 Sep; 16(17):4497-503. PubMed ID: 16824752
[TBL] [Abstract][Full Text] [Related]
2. Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivatives.
Meurer LC; Finke PE; Owens KA; Tsou NN; Ball RG; Mills SG; Maccoss M; Sadowski S; Cascieri MA; Tsao KL; Chicchi GG; Egger LA; Luell S; Metzger JM; Macintyre DE; Rupniak NM; Williams AR; Hargreaves RJ
Bioorg Med Chem Lett; 2006 Sep; 16(17):4504-11. PubMed ID: 16831551
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective preparation of a cyclopentane-based NK1 receptor antagonist bearing an unsymmetrically substituted sec-sec ether.
Kuethe JT; Marcoux JF; Wong A; Wu J; Hillier MC; Dormer PG; Davies IW; Hughes DL
J Org Chem; 2006 Sep; 71(19):7378-90. PubMed ID: 16958533
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
[TBL] [Abstract][Full Text] [Related]
5. NK1 antagonists based on seven membered lactam scaffolds.
Elliott JM; Carlson EJ; Chicchi GG; Dirat O; Dominguez M; Gerhard U; Jelley R; Jones AB; Kurtz MM; Tsao Kl; Wheeldon A
Bioorg Med Chem Lett; 2006 Jun; 16(11):2929-32. PubMed ID: 16574413
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydroindolizinone NK1 antagonists.
Bao J; Lu H; Morriello GJ; Carlson EJ; Wheeldon A; Chicchi GG; Kurtz MM; Tsao KL; Zheng S; Tong X; Mills SG; DeVita RJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2354-8. PubMed ID: 20188553
[TBL] [Abstract][Full Text] [Related]
7. Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists.
Giordanetto F; Karlsson O; Lindberg J; Larsson LO; Linusson A; Evertsson E; Morgan DG; Inghardt T
Bioorg Med Chem Lett; 2007 Aug; 17(15):4232-41. PubMed ID: 17532215
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones as NK(1) antagonists.
Seto S; Tanioka A; Ikeda M; Izawa S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1479-84. PubMed ID: 15713411
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.
Hoffmann T; Bös M; Stadler H; Schnider P; Hunkeler W; Godel T; Galley G; Ballard TM; Higgins GA; Poli SM; Sleight AJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1362-5. PubMed ID: 16332435
[TBL] [Abstract][Full Text] [Related]
10. Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists.
Pasternak A; Goble SD; Doss GA; Tsou NN; Butora G; Vicario PP; Ayala JM; Struthers M; Demartino JA; Mills SG; Yang L
Bioorg Med Chem Lett; 2008 Feb; 18(4):1374-7. PubMed ID: 18215519
[TBL] [Abstract][Full Text] [Related]
11. Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions.
Shue HJ; Chen X; Schwerdt JH; Paliwal S; Blythin DJ; Lin L; Gu D; Wang C; Reichard GA; Wang H; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Nomeir AA; Morgan CA; Varty GB; Shih NY
Bioorg Med Chem Lett; 2006 Feb; 16(4):1065-9. PubMed ID: 16290143
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a tetrahydropyran NK1 receptor antagonist via asymmetric conjugate addition.
Huffman MA; Smitrovich JH; Rosen JD; Boice GN; Qu C; Nelson TD; McNamara JM
J Org Chem; 2005 May; 70(11):4409-13. PubMed ID: 15903319
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
[TBL] [Abstract][Full Text] [Related]
14. Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor.
Morriello GJ; Chicchi G; Johnson T; Mills SG; Demartino J; Kurtz M; Tsao KL; Zheng S; Tong X; Carlson E; Townson K; Wheeldon A; Boyce S; Collinson N; Rupniak N; Devita RJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5925-32. PubMed ID: 20729082
[TBL] [Abstract][Full Text] [Related]
15. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
[TBL] [Abstract][Full Text] [Related]
16. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D
Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
Paliwal S; Reichard GA; Shah S; Wrobleski ML; Wang C; Stengone C; Tsui HC; Xiao D; Duffy RA; Lachowicz JE; Nomeir AA; Varty GB; Shih NY
Bioorg Med Chem Lett; 2008 Jul; 18(14):4168-71. PubMed ID: 18547807
[TBL] [Abstract][Full Text] [Related]
18. Novel lactam NK1 antagonists with anti-emetic activity.
Hollingworth GJ; Carlson EJ; Castro JL; Chicchi GG; Clark N; Cooper LC; Dirat O; Salvo JD; Elliott JM; Kilburn R; Kurtz MM; Rycroft W; Tattersall FD; Tsao KL; Swain CJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1197-201. PubMed ID: 16384700
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective synthesis of a novel 2-aza-7-oxabicyclo[3.3.0]octane as neurokinin-1 receptor antagonist.
Shishido Y; Ito F; Morita H; Ikunaka M
Bioorg Med Chem Lett; 2007 Dec; 17(24):6887-90. PubMed ID: 17967540
[TBL] [Abstract][Full Text] [Related]
20. Cyclic urea derivatives as potent NK1 selective antagonists.
Shue HJ; Chen X; Shih NY; Blythin DJ; Paliwal S; Lin L; Gu D; Schwerdt JH; Shah S; Reichard GA; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Liu F; Nomeir AA; Morgan CA; Varty GB
Bioorg Med Chem Lett; 2005 Sep; 15(17):3896-9. PubMed ID: 16019209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
